APA (7th ed.) Citation

JN, B., DA, N., J, K., N, P., R, M., MA, A., . . . JN, K. (2024). Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: Results of a phase 1 trial. Blood advances, 8(3), 802. https://doi.org/10.1182/bloodadvances.2023011470

Chicago Style (17th ed.) Citation

JN, Brudno, et al. "Transient Responses and Significant Toxicities of Anti-CD30 CAR T Cells for CD30+ Lymphomas: Results of a Phase 1 Trial." Blood Advances 8, no. 3 (2024): 802. https://doi.org/10.1182/bloodadvances.2023011470.

MLA (9th ed.) Citation

JN, Brudno, et al. "Transient Responses and Significant Toxicities of Anti-CD30 CAR T Cells for CD30+ Lymphomas: Results of a Phase 1 Trial." Blood Advances, vol. 8, no. 3, 2024, p. 802, https://doi.org/10.1182/bloodadvances.2023011470.